Profil
Krystof S.
Bankiewicz is the founder of Voyager Therapeutics, Inc. (founded in 2013) and Brain Neurotherapy Bio, Inc. (founded in 2018).
At Brain Neurotherapy Bio, Inc., he held the title of Chief Executive Officer from 2018 to 2024.
Currently, Dr. Bankiewicz is the Director-Interventional Neurology Center at The University of California, San Francisco.
Dr. Bankiewicz holds a doctorate degree from Uniwersytet Jagiellonski and Instytut Psychiatrii I Neurologii.
Aktiva positioner av Krystof S. Bankiewicz
| Företag | Position | Start |
|---|---|---|
The University of California, San Francisco
The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Företagsledare/Principal | - |
Tidigare kända positioner av Krystof S. Bankiewicz
| Företag | Position | Slut |
|---|---|---|
Brain Neurotherapy Bio, Inc.
Brain Neurotherapy Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Develops transformative neurological gene therapies that restore and preserve health and well-being | Verkställande Direktör | 2024-02-01 |
| VOYAGER THERAPEUTICS, INC. | Grundare | - |
Krystof S. Bankiewiczs utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
The University of California, San Francisco
The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Uniwersytet Jagiellonski
Uniwersytet Jagiellonski Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Instytut Psychiatrii I Neurologii
Instytut Psychiatrii I Neurologii Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Voyager Therapeutics, Inc.
Voyager Therapeutics, Inc. BiotechnologyHealth Technology Develops gene therapies for fatal and debilitating diseases of the central nervous system | Health Technology |
Brain Neurotherapy Bio, Inc.
Brain Neurotherapy Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Develops transformative neurological gene therapies that restore and preserve health and well-being | Commercial Services |
















